TUG1 and neoplasm: Taken together, m6A‐mediated upregulation of Tug1 is closely related to tumor immunity, and it could inhibit the antitumor immune response of CD8+ T cells by promoting Pdl1 expression, and inhibiting the phagocytosis function of macrophages toward cancer cells by promoting Cd47 expression.